It is know for some years that Alzheimer's disease is characterised by two types of lesions, amyloid plaques and degenerated tau protein. Cholesterol plays an important role in the physiopathology of this disease.
Excess brain cholesterol cannot freely cross the blood-brain barrier; to be eliminated it must be converted into 24-hydroxycholesterol (24-OHC) by the enzyme CYP46A1 (cholesterol-24-hydroxylase).
Researchers proposed the hypothesis that increasing the efflux of cholesterol from the brain by overexpressing CYP46A1 might have a beneficial effect on the elements of Alzheimer pathology.
The first step in this work made it possible to show that injecting a viral vector, AAV-CYP46A1, effectively corrects a mouse model of amyloid pathology of the disease, the APP23 mouse. CYP46A1 thus appears to be a therapeutic target for Alzheimer's disease.
Conversely, in vivo inhibition of CYP46A1 in the mice, using antisense RNA molecules delivered by an AAV vector administered to the hippocampus, induces an increase in the production of Aß peptides, abnormal tau protein, neuronal death and hippocampal atrophy, leading to memory problems. Together these elements reproduce a phenotype mimicking Alzheimer's disease according to publication in Human Molecular Genetics.
These results further confirm the relevance of CYP46A1 as a potential therapeutic target (work published in Brain recently).
Edited
Latest News
Low-flavanol diet drives ag…
By newseditor
Posted 05 Jun
NLRP12 as a new drug target…
By newseditor
Posted 05 Jun
How Botox enters the brain…
By newseditor
Posted 04 Jun
Gut microbiome changes link…
By newseditor
Posted 04 Jun
Artificial intelligence sys…
By newseditor
Posted 03 Jun
Other Top Stories
Bacterial natural product from an amino acid independent of the rib…
Read more
Virulence factor of the influenza A virus mapped in real-time
Read more
ALS progression linked to microbiome!
Read more
Mosquito spit protein controls blood feeding
Read more
Immune system response immediately after bacterial infection
Read more
Protocols
Optical opening of the bloo…
By newseditor
Posted 04 Jun
Protocol to establish a gen…
By newseditor
Posted 03 Jun
Metaboverse enables automat…
By newseditor
Posted 02 Jun
Ratphones: An Affordable To…
By newseditor
Posted 31 May
BigNeuron: A resource to be…
By newseditor
Posted 29 May
Publications
Dietary flavanols restore h…
By newseditor
Posted 05 Jun
Profiling the metabolome of…
By newseditor
Posted 05 Jun
NLRP12-PANoptosome activate…
By newseditor
Posted 05 Jun
Multifaceted nanoparticles:…
By newseditor
Posted 05 Jun
Transcriptional drifts asso…
By newseditor
Posted 05 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar